TScan Therapeutics Reports Board Resignations and Committee Changes
TScan Therapeutics, Inc.
Subscribe to track TCRX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
TScan Therapeutics Reports Board Resignations and Committee Changes
Company: TScan Therapeutics, Inc. (TCRX)
Form: 8-K | Filed: 2026-10-16
Significance: Low
Governance Event: • Event: Departure of Directors (Item 5.02) • Departing Directors: Garry Nicholson, Gabriela Gruia, M.D. • Effective Date: October 13, 2026 • Disagreements: None noted
Committee Reconstitution: • Nominating & Corporate Governance: R. Keith Woods (Chair), Stephen Biggar, Katina Dorton • Audit Committee: Katina Dorton, Barbara Klencke, R. Keith Woods
Key Insight: Routine board departures with no operational disagreements reported. No open-market equity transactions or dilutive events took place in connection with this filing.
Comprehensive Analysis
SEC Filing Analysis: TScan Therapeutics, Inc. (TCRX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Directors Garry Nicholson and Gabriela Gruia, M.D., resigned from the Board with no reported disagreements, prompting routine committee reassignments.
- Market Impact: Neutral; standard corporate governance update with no capital structure changes or share transactions.
Company Information
| Field | Value |
|---|---|
| Company | TScan Therapeutics, Inc. |
| Ticker Symbol | TCRX |
| CIK | 0001783328 |
| Exchange | The Nasdaq Global Market |
Insider Information
| Field | Value |
|---|---|
| Name | Garry Nicholson / Gabriela Gruia, M.D. |
| Title/Position | Directors |
| Relationship | Directors |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 8-K (Item 5.02) |
| Transaction Date | None (N/A) |
| Transaction Type | None (Board Resignation) |
| Shares Transacted | 0 |
| Total Value | $0.00 |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0.00 |
| % of Market Cap ($20.0M) | 0.00% |
| Shares Transacted | 0 |
| % of Shares Outstanding (65.35M) | 0.00% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a micro-cap valuation of approximately $20 million, non-transactional administrative filings typically have negligible direct market impact.
- Dilution & Ownership Impact: Zero share dilution or equity restructuring occurred as part of this event.
Market Impact Analysis
- Stock Impact Prediction: Neutral
- Reasoning: Resignations were explicitly confirmed not to stem from any disagreement regarding company operations, policies, or practices.
- Volume & Sentiment: Expected volume impact is minimal; governance adjustments are not anticipated to alter investor sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.